✦ LIBER ✦

The effect of recombinant activated factor VII (NOVOSEVEN®) on outcomes and adverse events in cardiac surgery patients

✍ Scribed by L. Phillips; D. Dinh; B. Billah; C. Reid; P. Cameron

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THE USE OF RECOMBINANT ACTIVATED FACTOR

✍ P. McCall; S. Dunkley; R. Lindeman; J. Brereton; P. Cameron; L. Phillips 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Consensus protocol for the use of recomb

✍ P. L. F. GIANGRANDE; J. T. WILDE; B. MADAN; C. A. LUDLAM; E. G. D. TUDDENHAM; N. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Effect of Recombinant Activated Factor V

✍ M. Al Douri; T. Shafi; D. Al Khudairi; E. Al Bokhari; L. Black; N. Akinwale; M. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Recombinant activated factor VII in the

✍ C. C. Hsia; J. H. Zurawska; M. Z. Y. Tong; K. Eckert; V. C. McAlister; I. H. Chi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Clinical significance of coagulation stu

✍ Alfred Ian Lee; Federico Campigotto; James D. Rawn; Donna Neuberg; Richard M. Ka 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Recombinant, activated factor VII for su

✍ Guglielmo Mariani; Alberto Dolce; Angelika Batorova; Günter Auerswald; Jean Fran 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB